FRPT vs IPAR
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Freshpet exhibits a stable financial foundation with a Piotroski F-Score of 4/9 and an exceptionally strong liquidity profile (Current Ratio 5.54). While the stock trades at a significant premium to its Graham Number ($38.72), it remains below its growth-based intrinsic value of $79.65. Explosive earnings growth (79.2% YoY) is the primary bullish driver, yet this is offset by a high PEG ratio of 3.77 and a bearish technical trend. The company is transitioning from a loss-making entity to a profitable one, but valuation remains stretched relative to revenue growth.
IPAR exhibits exceptional financial health, highlighted by a perfect Piotroski F-Score of 9/9 and a very low Debt/Equity ratio of 0.19. While the current price of $93.00 sits above the conservative Graham Number ($56.90), it remains significantly discounted relative to its growth-based intrinsic value of $154.58 and the sector average P/E of 31.82. Despite bearish short-term technicals and recent insider selling, the company's strong ROE (20.34%) and consistent earnings beat track record suggest a high-quality compounder. The valuation gap between the current price and the analyst target of $111.20 provides a compelling margin of safety.
Compare Another Pair
Related Comparisons
FRPT vs IPAR: Head-to-Head Comparison
This page compares Freshpet, Inc. (FRPT) and Interparfums, Inc. (IPAR) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.